{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000962","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.216855+00:00","generated_at":"2026-06-10T20:59:58.067253+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioSig raises ~$550K in PIPE; issues shares and warrants to accredited investors","bullets":["Sold 990,954 shares at $0.55502/share and warrants for 495,477 shares at $0.49252/share.","Aggregate consideration of $549,999.29; warrants exercisable 6 months after issuance, expire in 5.5 years.","Issued 67,565-share warrant to Laidlaw & Company as compensation for placement services.","Transaction exempt from registration under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000962","json":"https://secwatch.observer/filing/0001185185-23-000962.json","markdown":"https://secwatch.observer/filing/0001185185-23-000962.md","text":"https://secwatch.observer/filing/0001185185-23-000962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000962/0001185185-23-000962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000962/biosig20230912_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T20:59:58.067253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eff82bcaea69f53333abefec087a77bd44462548","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $549,999.29 (effective 2023-09-12).","evidence_excerpt":"On September 12, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 990,954 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.55502 per share, and warrants (the “Warrants”) to purchase up to 495,477 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at an exercise price of $0.49252 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $549,999.29","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000962/0001185185-23-000962-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$549,999.29"},{"label":"Effective","value":"2023-09-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}